Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when compared to fair value?
One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Molson Coors Beverage Company (TAP - Free Report) stock into this equation and find out if it is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks:
A key metric that value investors always look at is the Price to Earnings Ratio, or PE for short. This shows us how much investors are willing to pay for each dollar of earnings in a given stock, and is easily one of the most popular financial ratios in the world. The best use of the PE ratio is to compare the stock’s current PE ratio with: a) where this ratio has been in the past; b) how it compares to the average for the industry/sector; and c) how it compares to the market as a whole.
On this front, Molson Coors Beverage has a trailing twelve months PE ratio of 7.52, as you can see in the chart below:
This level actually compares favorably with the market at large, as the PE for the S&P 500 stands at about 23.51. If we focus on the long-term PE trend, Molson Coors Beverage’s current PE level puts it below its midpoint over the past five years. Moreover, the current level is fairly below the highs for this stock, suggesting it might be a good entry point.
However, the stock’s PE also compares unfavorably with the Zacks Consumer Discretionary sector’s trailing twelve months PE ratio, which stands at 22.33. At the very least, this indicates that the stock is slightly undervalued right now, compared to its peers.
We should also point out that Molson Coors Beverage has a forward PE ratio (price relative to this year’s earnings) of just 9.15, so it is fair to expect an increase in the company’s share price in the near future.
Another key metric to note is the Price/Sales ratio. This approach compares a given stock’s price to its total sales, where a lower reading is generally considered better. Some people like this metric more than other value-focused ones because it looks at sales, something that is far harder to manipulate with accounting tricks than earnings.
Right now, Molson Coors Beverage has a P/S ratio of about 0.72. This is substantially lower than the S&P 500 average, which comes in at 4.06 right now. Also, as we can see in the chart below, this is somewhat below the highs for this stock in particular over the past few years.
Broad Value Outlook
In aggregate, Molson Coors Beverage currently has a Value Score of A, putting it into the top 20% of all stocks we cover from this look. This makes Molson Coors Beverage a solid choice for value investors, and some of its other key metrics make this pretty clear too.
For example, the PEG ratio for Molson Coors Beverage is just 1.53, a level that is lower than the industry average of 3.74. The PEG ratio is a modified PE ratio that takes into account the stock’s earnings growth rate. Additionally, its P/CF ratio (another great indicator of value) comes in at 3.93, which is better than the industry average of 15.87. Clearly, TAP is a solid choice on the value front from multiple angles.
What About the Stock Overall?
Though Molson Coors Beverage might be a good choice for value investors, there are plenty of other factors to consider before investing in this name. In particular, it is worth noting that the company has a Growth Score of B and Momentum Score of D. This gives TAP a Zacks VGM score — or its overarching fundamental grade — of A. (You can read more about the Zacks Style Scores here >>)
Meanwhile, the company’s recent earnings estimates have been encouraging. The current year estimate witnessed six upward revisions in the past sixty days compared to one downward revision, whereas the full year 2021 estimate also witnessed six upward revisions compared to one downward revision in the same time period.
This has had a noticeable impact on the consensus estimate, as the full year 2021 consensus estimate improved 30.9% in the past two months, while the current year estimate improved 11% during the same time frame. You can see the consensus estimate trend and recent price action for the stock in the chart below:
Molson Coors Beverage Company Price and Consensus
So, value investors might want to wait for estimates, analyst sentiment and broader factors to turn around in this name first, but once that happens, this stock could be a compelling pick.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>